ANNX Annexon, Inc.

$5.29

Annexon, Inc. (ANNX) is expected to report earnings on November 11, 2026, before the market open. The consensus earnings estimate is a loss of $0.26 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +4.6% since its last earnings release on August 12, 2026.

Annexon Missed Consensus Estimates
Wednesday, August 12, 2026 · 6:05 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 11
Wednesday · Before Open
Earnings Whisper
-
vs ($0.26)
Rev est $37.5M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $5.30

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Annexon, Inc.

Annexon is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain and eye.

Sector

Healthcare

Industry

Biotechnology